Skip to content

ORBIMED ADVISORS LLC: BCAX position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ORBIMED ADVISORS LLC on BCAX, newest first. How the timeline and the estimate are built.

ORBIMED ADVISORS LLC held 0 BCAX shares at 2026-09-30 per its 13F-HR filed 2026-11-16.

the latest 13F is the newest step

  1. period ended2026-09-30
    13F 0 shares
    Change vs previous 13F -191,100 shares

    13F-HR 0001172661-26-005349 filed by ORBIMED ADVISORS LLC
    Accepted , ingested

    Exited: the 13F for this period no longer lists the position.

  2. period ended2026-06-30
    13F 191,100 shares
    Change vs previous 13F -476,200 shares

    0.11% of the 13F portfolio, value $5,673,759.

    13F-HR 0001172661-26-003740 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2026-03-31
    13F 667,300 shares
    Change vs previous 13F +458,200 shares

    0.29% of the 13F portfolio, value $13,272,597.

    13F-HR 0001172661-26-002369 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-12-31
    13F 209,100 shares
    Change vs previous 13F +209,100 shares

    0.07% of the 13F portfolio, value $3,519,153.

    13F-HR 0001172661-26-001119 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 0 shares
    Change vs previous 13F -298,301 shares

    13F-HR 0001172661-25-003514 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  6. period ended2025-03-31
    13F 298,301 shares
    Change vs previous 13F 0 shares

    0.09% of the 13F portfolio, value $3,886,862.

    13F-HR 0001172661-25-002355 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 298,301 shares
    Change vs previous 13F not available

    0.11% of the 13F portfolio, value $5,196,403.

    13F-HR 0001172661-25-001136 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).